The global market for Labeled Peptides was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Labeled Peptides with stable, non-radioactive isotopes are increasingly used for convenient detection in research. Isotope–labeled, or ‘heavy’ amino acids, are derived from natural amino acids by substitution of certain atoms (N, C, H) with their ‘heavy isotope’ variant. The most frequently substitutions are 12C by 13C (carbon-13), 14N by 15N (nitrogen-15), and 1H by 2H (deuterium).

North American market for Labeled Peptides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Labeled Peptides is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Labeled Peptides include Pepscan, JPT Peptide Technologies, PEPTIDE INSTITUTE, Merck, BIOSYNTAN GmbH, LifeTein, Eurogentec, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Labeled Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Labeled Peptides.

The Labeled Peptides market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Labeled Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Labeled Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Labeled Peptides Market Report

Report Metric	Details
Report Name	Labeled Peptides Market
Segment by Type	(Arg)9, FAM-labeled (Arg)9, TAMRA-labeled Others
Segment by Application	Protein Chemistry Immunology Histochemistry Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pepscan, JPT Peptide Technologies, PEPTIDE INSTITUTE, Merck, BIOSYNTAN GmbH, LifeTein, Eurogentec
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Labeled Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Labeled Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Labeled Peptides Market report?

Ans: The main players in the Labeled Peptides Market are Pepscan, JPT Peptide Technologies, PEPTIDE INSTITUTE, Merck, BIOSYNTAN GmbH, LifeTein, Eurogentec

What are the Application segmentation covered in the Labeled Peptides Market report?

Ans: The Applications covered in the Labeled Peptides Market report are Protein Chemistry, Immunology, Histochemistry, Others

What are the Type segmentation covered in the Labeled Peptides Market report?

Ans: The Types covered in the Labeled Peptides Market report are (Arg)9, FAM-labeled, (Arg)9, TAMRA-labeled, Others

1 Labeled Peptides Market Overview

1.1 Product Definition

1.2 Labeled Peptides by Type

1.2.1 Global Labeled Peptides Market Value Comparison by Type (2024 VS 2031)

1.2.2 (Arg)9, FAM-labeled

1.2.3 (Arg)9, TAMRA-labeled

1.2.4 Others

1.3 Labeled Peptides by Application

1.3.1 Global Labeled Peptides Market Value by Application (2024 VS 2031)

1.3.2 Protein Chemistry

1.3.3 Immunology

1.3.4 Histochemistry

1.3.5 Others

1.4 Global Labeled Peptides Market Size Estimates and Forecasts

1.4.1 Global Labeled Peptides Revenue 2020-2031

1.4.2 Global Labeled Peptides Sales 2020-2031

1.4.3 Global Labeled Peptides Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Labeled Peptides Market Competition by Manufacturers

2.1 Global Labeled Peptides Sales Market Share by Manufacturers (2020-2025)

2.2 Global Labeled Peptides Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Labeled Peptides Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Labeled Peptides, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Labeled Peptides, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Labeled Peptides, Product Type & Application

2.7 Global Key Manufacturers of Labeled Peptides, Date of Enter into This Industry

2.8 Global Labeled Peptides Market Competitive Situation and Trends

2.8.1 Global Labeled Peptides Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Labeled Peptides Players Market Share by Revenue

2.8.3 Global Labeled Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Labeled Peptides Market Scenario by Region

3.1 Global Labeled Peptides Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Labeled Peptides Sales by Region: 2020-2031

3.2.1 Global Labeled Peptides Sales by Region: 2020-2025

3.2.2 Global Labeled Peptides Sales by Region: 2026-2031

3.3 Global Labeled Peptides Revenue by Region: 2020-2031

3.3.1 Global Labeled Peptides Revenue by Region: 2020-2025

3.3.2 Global Labeled Peptides Revenue by Region: 2026-2031

3.4 North America Labeled Peptides Market Facts & Figures by Country

3.4.1 North America Labeled Peptides Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Labeled Peptides Sales by Country (2020-2031)

3.4.3 North America Labeled Peptides Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Labeled Peptides Market Facts & Figures by Country

3.5.1 Europe Labeled Peptides Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Labeled Peptides Sales by Country (2020-2031)

3.5.3 Europe Labeled Peptides Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Labeled Peptides Market Facts & Figures by Region

3.6.1 Asia Pacific Labeled Peptides Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Labeled Peptides Sales by Region (2020-2031)

3.6.3 Asia Pacific Labeled Peptides Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Labeled Peptides Market Facts & Figures by Country

3.7.1 Latin America Labeled Peptides Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Labeled Peptides Sales by Country (2020-2031)

3.7.3 Latin America Labeled Peptides Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Labeled Peptides Market Facts & Figures by Country

3.8.1 Middle East and Africa Labeled Peptides Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Labeled Peptides Sales by Country (2020-2031)

3.8.3 Middle East and Africa Labeled Peptides Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Labeled Peptides Sales by Type (2020-2031)

4.1.1 Global Labeled Peptides Sales by Type (2020-2025)

4.1.2 Global Labeled Peptides Sales by Type (2026-2031)

4.1.3 Global Labeled Peptides Sales Market Share by Type (2020-2031)

4.2 Global Labeled Peptides Revenue by Type (2020-2031)

4.2.1 Global Labeled Peptides Revenue by Type (2020-2025)

4.2.2 Global Labeled Peptides Revenue by Type (2026-2031)

4.2.3 Global Labeled Peptides Revenue Market Share by Type (2020-2031)

4.3 Global Labeled Peptides Price by Type (2020-2031)

5 Segment by Application

5.1 Global Labeled Peptides Sales by Application (2020-2031)

5.1.1 Global Labeled Peptides Sales by Application (2020-2025)

5.1.2 Global Labeled Peptides Sales by Application (2026-2031)

5.1.3 Global Labeled Peptides Sales Market Share by Application (2020-2031)

5.2 Global Labeled Peptides Revenue by Application (2020-2031)

5.2.1 Global Labeled Peptides Revenue by Application (2020-2025)

5.2.2 Global Labeled Peptides Revenue by Application (2026-2031)

5.2.3 Global Labeled Peptides Revenue Market Share by Application (2020-2031)

5.3 Global Labeled Peptides Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pepscan

6.1.1 Pepscan Company Information

6.1.2 Pepscan Description and Business Overview

6.1.3 Pepscan Labeled Peptides Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pepscan Labeled Peptides Product Portfolio

6.1.5 Pepscan Recent Developments/Updates

6.2 JPT Peptide Technologies

6.2.1 JPT Peptide Technologies Company Information

6.2.2 JPT Peptide Technologies Description and Business Overview

6.2.3 JPT Peptide Technologies Labeled Peptides Sales, Revenue and Gross Margin (2020-2025)

6.2.4 JPT Peptide Technologies Labeled Peptides Product Portfolio

6.2.5 JPT Peptide Technologies Recent Developments/Updates

6.3 PEPTIDE INSTITUTE

6.3.1 PEPTIDE INSTITUTE Company Information

6.3.2 PEPTIDE INSTITUTE Description and Business Overview

6.3.3 PEPTIDE INSTITUTE Labeled Peptides Sales, Revenue and Gross Margin (2020-2025)

6.3.4 PEPTIDE INSTITUTE Labeled Peptides Product Portfolio

6.3.5 PEPTIDE INSTITUTE Recent Developments/Updates

6.4 Merck

6.4.1 Merck Company Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Labeled Peptides Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Merck Labeled Peptides Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 BIOSYNTAN GmbH

6.5.1 BIOSYNTAN GmbH Company Information

6.5.2 BIOSYNTAN GmbH Description and Business Overview

6.5.3 BIOSYNTAN GmbH Labeled Peptides Sales, Revenue and Gross Margin (2020-2025)

6.5.4 BIOSYNTAN GmbH Labeled Peptides Product Portfolio

6.5.5 BIOSYNTAN GmbH Recent Developments/Updates

6.6 LifeTein

6.6.1 LifeTein Company Information

6.6.2 LifeTein Description and Business Overview

6.6.3 LifeTein Labeled Peptides Sales, Revenue and Gross Margin (2020-2025)

6.6.4 LifeTein Labeled Peptides Product Portfolio

6.6.5 LifeTein Recent Developments/Updates

6.7 Eurogentec

6.7.1 Eurogentec Company Information

6.7.2 Eurogentec Description and Business Overview

6.7.3 Eurogentec Labeled Peptides Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Eurogentec Labeled Peptides Product Portfolio

6.7.5 Eurogentec Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Labeled Peptides Industry Chain Analysis

7.2 Labeled Peptides Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Labeled Peptides Production Mode & Process Analysis

7.4 Labeled Peptides Sales and Marketing

7.4.1 Labeled Peptides Sales Channels

7.4.2 Labeled Peptides Distributors

7.5 Labeled Peptides Customer Analysis

8 Labeled Peptides Market Dynamics

8.1 Labeled Peptides Industry Trends

8.2 Labeled Peptides Market Drivers

8.3 Labeled Peptides Market Challenges

8.4 Labeled Peptides Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Pepscan

JPT Peptide Technologies

List of Tables

Table 1. Global Labeled Peptides Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Labeled Peptides Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Labeled Peptides Market Competitive Situation by Manufacturers in 2024

Table 4. Global Labeled Peptides Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Labeled Peptides Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Labeled Peptides Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Labeled Peptides Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Labeled Peptides Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Labeled Peptides, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Labeled Peptides, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Labeled Peptides, Product Type & Application

Table 12. Global Key Manufacturers of Labeled Peptides, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Labeled Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Labeled Peptides as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Labeled Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Labeled Peptides Sales by Region (2020-2025) & (K Units)

Table 18. Global Labeled Peptides Sales Market Share by Region (2020-2025)

Table 19. Global Labeled Peptides Sales by Region (2026-2031) & (K Units)

Table 20. Global Labeled Peptides Sales Market Share by Region (2026-2031)

Table 21. Global Labeled Peptides Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Labeled Peptides Revenue Market Share by Region (2020-2025)

Table 23. Global Labeled Peptides Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Labeled Peptides Revenue Market Share by Region (2026-2031)

Table 25. North America Labeled Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Labeled Peptides Sales by Country (2020-2025) & (K Units)

Table 27. North America Labeled Peptides Sales by Country (2026-2031) & (K Units)

Table 28. North America Labeled Peptides Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Labeled Peptides Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Labeled Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Labeled Peptides Sales by Country (2020-2025) & (K Units)

Table 32. Europe Labeled Peptides Sales by Country (2026-2031) & (K Units)

Table 33. Europe Labeled Peptides Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Labeled Peptides Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Labeled Peptides Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Labeled Peptides Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Labeled Peptides Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Labeled Peptides Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Labeled Peptides Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Labeled Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Labeled Peptides Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Labeled Peptides Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Labeled Peptides Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Labeled Peptides Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Labeled Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Labeled Peptides Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Labeled Peptides Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Labeled Peptides Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Labeled Peptides Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Labeled Peptides Sales (K Units) by Type (2020-2025)

Table 51. Global Labeled Peptides Sales (K Units) by Type (2026-2031)

Table 52. Global Labeled Peptides Sales Market Share by Type (2020-2025)

Table 53. Global Labeled Peptides Sales Market Share by Type (2026-2031)

Table 54. Global Labeled Peptides Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Labeled Peptides Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Labeled Peptides Revenue Market Share by Type (2020-2025)

Table 57. Global Labeled Peptides Revenue Market Share by Type (2026-2031)

Table 58. Global Labeled Peptides Price (US$/Unit) by Type (2020-2025)

Table 59. Global Labeled Peptides Price (US$/Unit) by Type (2026-2031)

Table 60. Global Labeled Peptides Sales (K Units) by Application (2020-2025)

Table 61. Global Labeled Peptides Sales (K Units) by Application (2026-2031)

Table 62. Global Labeled Peptides Sales Market Share by Application (2020-2025)

Table 63. Global Labeled Peptides Sales Market Share by Application (2026-2031)

Table 64. Global Labeled Peptides Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Labeled Peptides Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Labeled Peptides Revenue Market Share by Application (2020-2025)

Table 67. Global Labeled Peptides Revenue Market Share by Application (2026-2031)

Table 68. Global Labeled Peptides Price (US$/Unit) by Application (2020-2025)

Table 69. Global Labeled Peptides Price (US$/Unit) by Application (2026-2031)

Table 70. Pepscan Company Information

Table 71. Pepscan Description and Business Overview

Table 72. Pepscan Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Pepscan Labeled Peptides Product

Table 74. Pepscan Recent Developments/Updates

Table 75. JPT Peptide Technologies Company Information

Table 76. JPT Peptide Technologies Description and Business Overview

Table 77. JPT Peptide Technologies Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. JPT Peptide Technologies Labeled Peptides Product

Table 79. JPT Peptide Technologies Recent Developments/Updates

Table 80. PEPTIDE INSTITUTE Company Information

Table 81. PEPTIDE INSTITUTE Description and Business Overview

Table 82. PEPTIDE INSTITUTE Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. PEPTIDE INSTITUTE Labeled Peptides Product

Table 84. PEPTIDE INSTITUTE Recent Developments/Updates

Table 85. Merck Company Information

Table 86. Merck Description and Business Overview

Table 87. Merck Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Merck Labeled Peptides Product

Table 89. Merck Recent Developments/Updates

Table 90. BIOSYNTAN GmbH Company Information

Table 91. BIOSYNTAN GmbH Description and Business Overview

Table 92. BIOSYNTAN GmbH Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. BIOSYNTAN GmbH Labeled Peptides Product

Table 94. BIOSYNTAN GmbH Recent Developments/Updates

Table 95. LifeTein Company Information

Table 96. LifeTein Description and Business Overview

Table 97. LifeTein Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. LifeTein Labeled Peptides Product

Table 99. LifeTein Recent Developments/Updates

Table 100. Eurogentec Company Information

Table 101. Eurogentec Description and Business Overview

Table 102. Eurogentec Labeled Peptides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Eurogentec Labeled Peptides Product

Table 104. Eurogentec Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Labeled Peptides Distributors List

Table 108. Labeled Peptides Customers List

Table 109. Labeled Peptides Market Trends

Table 110. Labeled Peptides Market Drivers

Table 111. Labeled Peptides Market Challenges

Table 112. Labeled Peptides Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Labeled Peptides

Figure 2. Global Labeled Peptides Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Labeled Peptides Market Share by Type: 2024 & 2031

Figure 4. (Arg)9, FAM-labeled Product Picture

Figure 5. (Arg)9, TAMRA-labeled Product Picture

Figure 6. Others Product Picture

Figure 7. Global Labeled Peptides Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Labeled Peptides Market Share by Application: 2024 & 2031

Figure 9. Protein Chemistry

Figure 10. Immunology

Figure 11. Histochemistry

Figure 12. Others

Figure 13. Global Labeled Peptides Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Labeled Peptides Market Size (2020-2031) & (US$ Million)

Figure 15. Global Labeled Peptides Sales (2020-2031) & (K Units)

Figure 16. Global Labeled Peptides Average Price (US$/Unit) & (2020-2031)

Figure 17. Labeled Peptides Report Years Considered

Figure 18. Labeled Peptides Sales Share by Manufacturers in 2024

Figure 19. Global Labeled Peptides Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Labeled Peptides Players: Market Share by Revenue in Labeled Peptides in 2024

Figure 21. Labeled Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Labeled Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Labeled Peptides Sales Market Share by Country (2020-2031)

Figure 24. North America Labeled Peptides Revenue Market Share by Country (2020-2031)

Figure 25. United States Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Labeled Peptides Sales Market Share by Country (2020-2031)

Figure 28. Europe Labeled Peptides Revenue Market Share by Country (2020-2031)

Figure 29. Germany Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Labeled Peptides Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Labeled Peptides Revenue Market Share by Region (2020-2031)

Figure 36. China Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Labeled Peptides Sales Market Share by Country (2020-2031)

Figure 46. Latin America Labeled Peptides Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Labeled Peptides Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Labeled Peptides Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Labeled Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Labeled Peptides by Type (2020-2031)

Figure 56. Global Revenue Market Share of Labeled Peptides by Type (2020-2031)

Figure 57. Global Labeled Peptides Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Labeled Peptides by Application (2020-2031)

Figure 59. Global Revenue Market Share of Labeled Peptides by Application (2020-2031)

Figure 60. Global Labeled Peptides Price (US$/Unit) by Application (2020-2031)

Figure 61. Labeled Peptides Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions